Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Capital Expenditures (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Capital Expenditures for 4 consecutive years, with $89000.0 as the latest value for Q4 2019.

  • Quarterly Capital Expenditures rose 127.13% to $89000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $162000.0 through Dec 2019, down 8.99% year-over-year, with the annual reading at $116000.0 for FY2025, 213.51% up from the prior year.
  • Capital Expenditures for Q4 2019 was $89000.0 at Forte Biosciences, up from $36000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $688000.0 in Q2 2018, with the low at -$487000.0 in Q4 2016.
  • Average Capital Expenditures over 4 years is $29937.5, with a median of $43000.0 recorded in 2016.
  • Peak annual rise in Capital Expenditures hit 425.19% in 2018, while the deepest fall reached 226.82% in 2018.
  • Over 4 years, Capital Expenditures stood at -$487000.0 in 2016, then surged by 53.59% to -$226000.0 in 2017, then tumbled by 45.13% to -$328000.0 in 2018, then skyrocketed by 127.13% to $89000.0 in 2019.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $89000.0, $36000.0, and -$96000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.